COVID-19

News

Lilly asks FDA for emergency clearance for COVID-19 antibody...

Eli Lilly has asked the FDA for an Emergency Use Authorization for its COVID-19 antibody therapy, after announcing new efficacy data from an ongoing trial.

News

FDA gives COVID-19 vaccine ‘advice’ after White House blocks...

The FDA may have been blocked from issuing stricter guidelines for emergency approval of COVID-19 vaccines by the Trump administration, but it has still managed to make its new approach pub

News

GSK and Vir expand COVID-19 antibody trial after Trump's tre...

GlaxoSmithKline and partner Vir Biotechnology are to expand a trial of an experimental antibody to treat COVID-19, putting heat on Regeneron’s rival that has been famously used to treat pre

News

Roche working “around the clock” to tackle UK test supply pr...

Supplies of swabs for coronavirus and other critical NHS tests for diseases like cancer, diabetes and heart disease have been threatened by a failure at a facility operated by Roche.

News

Excel spreadsheet blamed for UK's COVID-19 test and trace wo...

An Excel spreadsheet was behind IT glitch that caused thousands of positive COVID-19 tests to be omitted from the UK’s official records, according to press reports.

News

"Tokyo, Japan - May 11, 2012: Pfizer building on May 11, 2012 in Tokyo. Pfizer is one of largest pharmaceutical companies worldwide with tremendous revenue $67.4 bn USD for 2011. It exists since 1849."

Race for COVID-19 vaccine hots up as EMA begins review of Bi...

The European Medicines Agency has begun a second “rolling review” of a potential coronavirus vaccine jointly developed by BioNTech and Pfizer, setting up a race with a rival from AstraZenec

Lilly asks FDA for emergency clearance for COVID-19 antibody...

FDA gives COVID-19 vaccine ‘advice’ after White House blocks...

GSK and Vir expand COVID-19 antibody trial after Trump's tre...

Roche working “around the clock” to tackle UK test supply pr...

Excel spreadsheet blamed for UK's COVID-19 test and trace wo...

Race for COVID-19 vaccine hots up as EMA begins review of Bi...

BioMarin ends year with $4.8bn play for Amicus

How to meet your physicians where they are online

COVID-19

Editor's Picks